المصدر: Scranton RE, Gazno JM, Rutty D, EzrokhM, Ccotta A. A randomed, double-bld, placebo-controlled trl to assess safety and toleraby durg treatment of type 2 dbetes wh usual dbetes therapy and eher Cycloset or placebo. BMC Endocr Dord. 2007 Jun 25;7:3. do 10.1186/1472-6823-7-3.
Gaziano JM, Cincotta AH, O'Connor CM, Ezrokhi M, Rutty D, Ma ZJ, Scranton RE. Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes. Diabetes Care. 2010 Jul;33(7):1503-8. doi: 10.2337/dc09-2009. Epub 2010 Mar 23. Erratum In: Diabetes Care. 2016 Oct;39(10 ):1846.
A Randomized, Double-Blind, Placebo-Controlled Trial to Assess Safety and Tolerability During Treatment of Type 2 Diabetes (T2DM) With Usual Diabetes Therapy (UDT) and Either Cycloset or Placebo

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00377676Test

المصدر: A Randomized, Double-Blind, Parallel-Group Trial to Assess the Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin in Patients With Type 2 Diabetes Mellitus

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00441363Test

المصدر: Single Dose Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets Following Administration of a Weight-Adjusted Dose in Male and Female Children and Adolescent Type 2 Diabetes Mellitus Subjects VS-PEDS BA-2010-V4

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02078440Test